Krka DD (FRA:KN8) FFO


FRA:KN8 Krka DD FRA:KN8
66 GF Score
Price €257.00
GF Value €148.68
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Krka DD FFO?

FFO (Funds from operations) only applies to REITs.

FRA:KN8
66GF Score
Krka DD FRA:KN8
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Krka DD (FRA:KN8) Overvalued in 2026?

Based on GuruFocus' analysis, Krka DD stock appears to be overvalued. The current stock price of €257.00 is trading 72.9% above its estimated GF Value™ of €148.68. GuruFocus considers Krka DD to be Significantly Overvalued.

Key valuation signals for FRA:KN8:

  • FFO:
  • GF Value™: €148.68 vs. price of €257.00 (72.9% above fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the FRA:KN8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Krka DD Business Description

Address Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company's products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, Eastern Europe region, and Others. The company derives a majority of its revenue from the European Union.
66GF Score

Get the complete analysis for FRA:KN8

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€257.00
Price
€148.68
GF Value